A paper published Sunday in the New England Journal of Medicine. For the small study, all 18 patients were given dostarlimab, a checkpoint inhibitor. The results were astounding. Every patient’s cancer disappeared, undetectable by physical examination, endoscopy, PET scans, or M.R.I. scans. Dr. Hanna K. Sanoff, MD, MPH, an associate professor of medicine in the Division of Oncolo … Read more